🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please checkout the updated version of our preprint, a result of a great collaboration with ⁦Bivona Lab @HarrisLabUMN with my mentors Charles Swanton and⁩ Julian Downward. Work done The Francis Crick Institute Swanton Lab #Downwardlab biorxiv.org/content/10.110…

Check out our abstract and poster EP08.02-217 Grateful for my mentor Collin Blakely MD, PhD , teammates Daniel Lucas Kerr and advocates AnnabelleGurwitch IASLC

Saying farewell and wishing the all the best to Tulpule Lab for the next step of his career at Memorial Sloan Kettering Cancer Center! Looking forward to more great science!

Happy holidays from the Bivona lab! 🎄🎅

Excited to learn from all the innovation at #AACR2023 We describe T-cell clonal expansion and tumor neoantigens in lung cancer as a potential clinical frontier - learn more at our poster session! section 21: abstract #605 Bivona Lab UCSF Health #immunology #CancerResearch

Finally this preprint! We describe functional ATM deficiency in Ewing sarcoma, a famously chemo-sensitive tumor, and link to native FET protein biology in DNA repair. Led by stellar postdoc Shruti Menon, in collab w/ Bivona Lab Sweet-Cordero Lab @ UCSF. biorxiv.org/content/10.110…

This Friday, June 2 UC San Francisco Cancer Research Seminar | Silvio Gutkind, PhD UC San Diego Health Moores Cancer Center GutkindLab "Exploiting Cancer Signaling Circuitries in the Era of Precision Medicine: Novel Multimodal Targeted and Immunotherapies" Hosted by Bivona Lab ow.ly/7vXH50OuCrw

Very proud to have this work finally out in Orli Bahcall! This was a wonderful team effort; I would like to thank Manasi Mayekar and Bivona Lab. It was a privilege to work with our collaborators Debbie Caswell and Charles Swanton from The Francis Crick Institute!

I am excited to announce the publication of our manuscript out today, with Philippe Gui, Charles Swanton, Swanton Lab, Bivona Lab, @Downwardlab, and The Harris Lab! 🧵 1/15 nature.com/articles/s4158…

In an international collaboration between @bivonaLabUCSF and The Harris Lab in the USA and @Drmcaswell Swanton Lab and #DownwardLab at the Crick, researchers found that the mutagenic enzyme APOBEC3B can contribute to targeted cancer therapy resistance nature.com/articles/s4158…

Thanks Cancer Discovery for highlighting our work showing the complex and context dependant effect of APOBEC3B on lung tumor evolution and targeted cancer therapy resistance! aacrjournals.org/cdnews/news/12…

Members of the Bivona lab at #AACR24 last week!

Just released on Nature Cancer: "PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors in myeloma and breast cancer in both pre-clinical and clinical models." Congrats to Bivona Lab! t.ly/ASZ8p

Just out in Nature Communications! Drs. Trever Bivona Bivona Lab, Jack Roth Jack A. Roth, M.D. and team uncover how the FAK-YAP signaling axis drives drug-tolerant cells and residual disease in lung cancer. #lungcancer #cancerresearch #ARTNetPublication 👇 pubmed.ncbi.nlm.nih.gov/38702301/

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer | Bivona Lab Roose Lab UCSF UC San Francisco via Nature Communications pubmed.ncbi.nlm.nih.gov/38702301/

Pleased to report the results of our clinical trial: Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung #JCO #EGFR ascopubs.org/doi/10.1200/JC… Thank you to all of the patients who participated.

Dr. Trever Bivona Bivona Lab presents on the progress of the BAATAAR-UP Center, which focuses on acquired resistance in lung cancer. #ARTNetAnnual

Join the Bivona Lab team at #AACR25 Chicago on April 29th! Tadashi Manabe MD, PhD 2:30-4:00 PM, Minisymposium Room S102 Yu-Ting 2:00-5:00 PM, Poster Section 18 Nilanjana Chatterjee 2:00-5:00 PM, Poster Section 17 Stop by to discuss our latest research findings! UCSF Helen Diller Family Comprehensive Cancer Ctr UC San Francisco